Funder
Innovation foundation of Southwest Hospital
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Lee S, Lee YB, Choe SJ, Lee WS (2019) Adverse sexual effects of treatment with finasteride or dutasteride for male androgenetic alopecia: a systematic review and meta-analysis. Acta Derm Venereol 99(1):12–17
2. Xu F, Sheng YY, Mu ZL, Lou W, Zhou J, Ren YT, Qi SS, Wang XS, Fu ZW, Yang QP (2009) Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study. Br J Dermatol 160(3):629–632
3. Wang TL, Zhou C, Shen YW, Wang XY, Ding XL, Tian S, Liu Y, Peng GH, Xue SQ, Zhou JE, Wang RL, Meng XM, Pei GD, Bai YH, Liu Q, Li H, Zhang JZ (2010) Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol 162(4):843–847
4. Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA (2018) A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drugs Dermatol 17(4):457–463
5. Suchonwanit P, Srisuwanwattana P, Chalermroj N, Khunkhet S (2018) A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol 32(12):2257–2263
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献